PHILADELPHIA — Perelman School of Medicine researchers Thomas Curran, PhD, professor of Pathology and Laboratory Medicine, and Gary A. Koretzky, MD, PhD, vice chair for research and chief scientific officer, Department of Medicine, and are among the 220 elected to the 2012 class of members of the American Academy of Arts and Sciences.
One of the nation's most prestigious honorary societies, the Academy is also a leading center for independent policy research. The current membership includes some of the world's most accomplished leaders from academia, business, public affairs, the humanities and the arts.
Gary A. Koretzky is also a Francis C. Wood professor in the Department of Medicine. Through investigations of the regulation of blood cell formation and movement, Koretzky has made inroads into understanding the complexities of immune system function.
Thomas Curran is also an investigator at the Abramson Family Cancer Research Institute and deputy scientific director at the Children's Hospital of Philadelphia. Curran's studies of the molecular basis of brain cell growth have informed new strategies to treat pediatric brain tumors. He is an elected member of the Institute of Medicine and of the Royal Society.
The other Penn winners admitted to this years' class are Robert M. Seyfarth, professor of psychology, George J. Mailath, Walter H. Annenberg Professor in the social sciences and professor of economics, and Michael Kearns, professor and National Center Chair in Resource Management and Technology, Computer and Information Science Department.
An alphabetical list of the 220 new members is at http://www.amacad.org/news/alphalist2012.pdf.
The new class will be inducted at a ceremony on Oct. 6, at the Academy's headquarters in Cambridge, Mass. For full release on all Penn winners, visit http://www.upenn.edu/pennnews/news/five-penn-professors-elected-american-academy-arts-and-sciences.
Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, excellence in patient care, and community service. The organization consists of the University of Pennsylvania Health System and Penn’s Raymond and Ruth Perelman School of Medicine, founded in 1765 as the nation’s first medical school.
The Perelman School of Medicine is consistently among the nation's top recipients of funding from the National Institutes of Health, with $550 million awarded in the 2022 fiscal year. Home to a proud history of “firsts” in medicine, Penn Medicine teams have pioneered discoveries and innovations that have shaped modern medicine, including recent breakthroughs such as CAR T cell therapy for cancer and the mRNA technology used in COVID-19 vaccines.
The University of Pennsylvania Health System’s patient care facilities stretch from the Susquehanna River in Pennsylvania to the New Jersey shore. These include the Hospital of the University of Pennsylvania, Penn Presbyterian Medical Center, Chester County Hospital, Lancaster General Health, Penn Medicine Princeton Health, and Pennsylvania Hospital—the nation’s first hospital, founded in 1751. Additional facilities and enterprises include Good Shepherd Penn Partners, Penn Medicine at Home, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.
Penn Medicine is an $11.1 billion enterprise powered by more than 49,000 talented faculty and staff.